These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7681090)

  • 1. Comparative study of bullous pemphigoid antigens among Japanese, British, and U.S. patients indicates similar antigen profiles with the 170-kD antigen present both in the basement membrane and on the keratinocyte cell membrane.
    Hashimoto T; Ebihara T; Ishiko A; Shimizu H; Bhogal BS; Black MM; Stanley JR; Nishikawa T
    J Invest Dermatol; 1993 Apr; 100(4):385-9. PubMed ID: 7681090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 230-kD basic protein is the major bullous pemphigoid antigen.
    Mueller S; Klaus-Kovtun V; Stanley JR
    J Invest Dermatol; 1989 Jan; 92(1):33-8. PubMed ID: 2462597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The major cicatricial pemphigoid antigen is a 180-kD protein that shows immunologic cross-reactivities with the bullous pemphigoid antigen.
    Bernard P; Prost C; Durepaire N; Basset-Seguin N; Didierjean L; Saurat JH
    J Invest Dermatol; 1992 Aug; 99(2):174-9. PubMed ID: 1629629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two groups of bullous pemphigoid antigens are identified by affinity-purified antibodies.
    Meyer LJ; Taylor TB; Kadunce DP; Zone JJ
    J Invest Dermatol; 1990 May; 94(5):611-6. PubMed ID: 2182719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of bullous pemphigoid with antibodies against intercellular 130 kd antigen.
    Takahashi H; Wada T; Matsuo S; Iwatsuki K; Iizuka H
    J Dermatol; 1995 Aug; 22(8):576-81. PubMed ID: 7560455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of bullous pemphigoid with antidesmoplakin autoantibodies.
    Watanabe K; Hashimoto T; Ishiko A; Shimizu H; Nishikawa T
    Dermatology; 1994; 189 Suppl 1():126-8. PubMed ID: 8049553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a basement membrane zone antigen reactive with circulating IgA antibody in ocular cicatricial pemphigoid.
    Smith EP; Taylor TB; Meyer LJ; Zone JJ
    J Invest Dermatol; 1993 Oct; 101(4):619-23. PubMed ID: 8409534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical manifestations in 100 Japanese bullous pemphigoid cases in relation to autoantigen profiles.
    Tanaka M; Hashimoto T; Dykes PJ; Nishikawa T
    Clin Exp Dermatol; 1996 Jan; 21(1):23-7. PubMed ID: 8689764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a novel basement membrane antigen (p84) defined by sera with antibodies to both the epidermal and dermal side of split skin.
    Gao SQ; Bystryn JC
    J Invest Dermatol; 1994 Feb; 102(2):236-40. PubMed ID: 8106753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of the relationship of the 230-kD and 180-kD bullous pemphigoid antigens.
    Robledo MA; Kim SC; Korman NJ; Stanley JR; Labib RS; Futamura S; Anhalt GJ
    J Invest Dermatol; 1990 Jun; 94(6):793-7. PubMed ID: 2192002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of bullous pemphigoid antigen synthesized by cultured human squamous cell carcinoma cells.
    Yamane Y; Kitajima Y; Yaoita H
    J Invest Dermatol; 1989 Aug; 93(2):220-3. PubMed ID: 2666514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen specificities of antibasement membrane zone antibodies: immunofluorescence and Western immunoblotting studies.
    Muramatsu T; Shirai T; Iida T; Yamashina Y; Sakamoto K
    Arch Dermatol Res; 1988; 280(7):411-5. PubMed ID: 2462854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactivity of autoantibodies from patients with defined subepidermal bullous diseases against 1 mol/L salt-split skin. Specificity, sensitivity, and practical considerations.
    Lazarova Z; Yancey KB
    J Am Acad Dermatol; 1996 Sep; 35(3 Pt 1):398-403. PubMed ID: 8784276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of basement membrane zone antigens defined by antibodies that react to both the epidermal and dermal side of 1 M sodium chloride split skin.
    Niimi Y; Zhu ZX; Bystryn JC
    J Invest Dermatol; 1991 Aug; 97(2):312-7. PubMed ID: 1712821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bullous pemphigoid and cicatricial pemphigoid: immunoblotting detection of involved autoantigens.
    Sarret Y; Reano A; Nicolas JF; Su H; Thivolet J
    Autoimmunity; 1989; 2(2):145-53. PubMed ID: 2491598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of 230-kD bullous pemphigoid antigen associated with the detergent-insoluble fraction of cultured keratinocytes.
    Thacher SM; Hefti PL
    J Invest Dermatol; 1991 Jan; 96(1):139-43. PubMed ID: 1987289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of different circulating autoantibodies in patients with bullous pemphigoid and pemphigus vulgaris by means of immunoblotting.
    Kiss M; Husz S; Molnár K; Dobozy A
    Acta Microbiol Immunol Hung; 1996; 43(2-3):115-23. PubMed ID: 8876727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection and partial characterization of ocular cicatricial pemphigoid antigens on COLO and SCaBER tumor cell lines.
    Mohimen A; Neumann R; Foster CS; Ahmed AR
    Curr Eye Res; 1993 Aug; 12(8):741-52. PubMed ID: 8222735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneous bullous pemphigoid antibodies: detection and characterization by immunoblotting when absent by indirect immunofluorescence.
    Bernard P; Didierjean L; Denis F; Saurat JH; Bonnetblanc JM
    J Invest Dermatol; 1989 Feb; 92(2):171-4. PubMed ID: 2645366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a 160-kD molecule as a component of the basement membrane zone and as a minor bullous pemphigoid antigen.
    Zhu XJ; Niimi Y; Bystryn JC
    J Invest Dermatol; 1990 Jun; 94(6):817-21. PubMed ID: 1693941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.